Fluidigm announces availability of Access Array Barcode Library for Ion Torrent PGM

NewsGuard 100/100 Score

Fluidigm Corporation (NASDAQ:FLDM) today announced the availability of the Access Array™ Barcode Library for the Ion Torrent Personal Genome Machine (PGM) sequencer. This barcode library allows multiplexing of up to 96 different samples in a single sequencing run.

"The Access Array Barcode Library for the Ion Torrent PGM enables the growing base of Ion Torrent users to dramatically improve their sample preparation for amplicon sequencing. The library uses a bidirectional amplicon tagging approach to allow reads to be obtained from both ends and across the full length of the amplicon with single-read sequencing. This eliminates the need for paired-end read sequencing," said Gajus Worthington, Fluidigm President and CEO.

The Fluidigm Access Array System prepares amplicons for resequencing without the need for any additional library preparation and can operate with any next-generation sequencer (NGS) on the market. It prepares these amplicons in just hours, instead of days, and performs the sample preparation for less than $10 per sample. In addition, using the Access Array Barcode Libraries developed for the Illumina, Roche, and Ion Torrent sequencing platforms, researchers can test the same amplicon pools to cross-validate sequencing results across different NGS platforms.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combining health data with whole genome sequence data in cancer patients can help doctors provide more tailored care